Controlled Release Oral Dosage Formulations Comprising A Core And One Or More Barrier Layers

Patent No. EP2063872 (titled "Controlled Release Oral Dosage Formulations Comprising A Core And One Or More Barrier Layers") was filed by Jagotec on Aug 29, 2007. The application was issued on Dec 4, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
AECHTERFeb 5, 2016TER MEER UND PARTNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2063872

JAGOTEC
Application Number
EP07801970A
Filing Date
Aug 29, 2007
Status
Patent Maintained As Amended
Nov 1, 2019
Publication Date
Dec 4, 2019